Search

Search Constraints

You searched for: Author/Creator Park, G

Search Results

5. DOP86 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease: A phase 3, randomised, placebo-controlled study (LIBERTY-CD). (30th January 2023)